Who invested in Syremis Therapeutics?
Syremis Therapeutics's investors include Google Ventures and Bain Capital Life Sciences.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 11 months ago
Funding summaryUpdated 26 Oct 2026
$165Mraised across 1 round since 2025, from 1 source
Syremis Therapeutics's investors include Google Ventures and Bain Capital Life Sciences.
Syremis Therapeutics has raised $165M across 1 round since 2025.
Syremis Therapeutics's most recent round was a Series A of $165M in Dec 2025.
Its most recent round, $165M in Dec 2025, is also its largest on record.
Syremis Therapeutics's first round on record, in Dec 2025, was backed by Google Ventures and Bain Capital Life Sciences.
Syremis Therapeutics's latest named round is a Series A, in Dec 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.